130 related articles for article (PubMed ID: 11029847)
21. Impact of Pharmacy Intervention on Prior Authorization Success and Efficiency at a University Medical Center.
Cutler T; She Y; Barca J; Lester S; Xing G; Patel J; Melnikow J
J Manag Care Spec Pharm; 2016 Oct; 22(10):1167-71. PubMed ID: 27668565
[TBL] [Abstract][Full Text] [Related]
22. Third party bargaining and contract terms: a link over time?
Brooks JM; Doucette WR; Sorofman BA
J Am Pharm Assoc (Wash); 2002; 42(3):420-7. PubMed ID: 12030628
[TBL] [Abstract][Full Text] [Related]
23. Expenditures for psychotropic medications in the United States in 1985.
Zorc JJ; Larson DB; Lyons JS; Beardsley RS
Am J Psychiatry; 1991 May; 148(5):644-7. PubMed ID: 2018168
[TBL] [Abstract][Full Text] [Related]
24. Financial impact of patients enrolled in a medication adherence program at an independent community pharmacy.
Clifton CL; Branham AR; Hayes HH; Moose JS; Rhodes LA; Marciniak MW
J Am Pharm Assoc (2003); 2018; 58(4S):S109-S113. PubMed ID: 30006182
[TBL] [Abstract][Full Text] [Related]
25. Pharmacy performance while providing continuous medication monitoring.
Doucette WR; McDonough RP; Herald F; Goedken A; Funk J; Deninger MJ
J Am Pharm Assoc (2003); 2017; 57(6):692-697. PubMed ID: 28844583
[TBL] [Abstract][Full Text] [Related]
26. Entry of new pharmacies in the deregulated Norwegian pharmaceuticals market--consequences for costs and availability.
Rudholm N
Health Policy; 2008 Aug; 87(2):258-63. PubMed ID: 18164509
[TBL] [Abstract][Full Text] [Related]
27. Analysis of pharmacists' interventions on electronic versus traditional prescriptions in 2 community pharmacies.
Gilligan AM; Miller K; Mohney A; Montenegro C; Schwarz J; Warholak TL
Res Social Adm Pharm; 2012; 8(6):523-32. PubMed ID: 22264963
[TBL] [Abstract][Full Text] [Related]
28. Utilization patterns and medication adherence in patients with type 2 diabetes: variations based on type of pharmacy (chain vs independent).
Kalsekar I; Sheehan C; Peak A
Res Social Adm Pharm; 2007 Dec; 3(4):378-91. PubMed ID: 18082874
[TBL] [Abstract][Full Text] [Related]
29. Financial impact from in-office dispensing of oral chemotherapy.
Howard A; Kerr J; McLain M; Modlin J
J Oncol Pharm Pract; 2019 Oct; 25(7):1570-1575. PubMed ID: 30249154
[TBL] [Abstract][Full Text] [Related]
30. Financial Impact of Medically Integrated Pharmacy Interventions on Oral Oncolytic Prescriptions.
Darling JO; Starkey AJ; Nubla JJ; Reff MJ
JCO Oncol Pract; 2022 Jul; 18(7):e1225-e1230. PubMed ID: 35561289
[TBL] [Abstract][Full Text] [Related]
31. Pharmacy communications with physician offices to clarify prescriptions.
Smith M; Sprecher B
J Am Pharm Assoc (2003); 2017; 57(2):178-182. PubMed ID: 28161301
[TBL] [Abstract][Full Text] [Related]
32. Principles of economics crucial to pharmacy students' understanding of the prescription drug market.
Rattinger GB; Jain R; Ju J; Mullins CD
Am J Pharm Educ; 2008 Jun; 72(3):61. PubMed ID: 18698403
[TBL] [Abstract][Full Text] [Related]
33. Application of concentration ratios to analyze the phenomenon of "next-door" pharmacy in Taiwan.
Ji Chen T; Chou LF; Hwang SJ
Clin Ther; 2006 Aug; 28(8):1225-1230. PubMed ID: 16982300
[TBL] [Abstract][Full Text] [Related]
34. State Medicaid pharmacy payments and their relation to estimated costs.
Adams EK; Kreling DH; Gondek K
Health Care Financ Rev; 1994; 15(3):25-42. PubMed ID: 10137796
[TBL] [Abstract][Full Text] [Related]
35. Patient counseling in community pharmacy and its relationship with prescription payment methods and practice settings.
Raisch DW
Ann Pharmacother; 1993 Oct; 27(10):1173-9. PubMed ID: 8251681
[TBL] [Abstract][Full Text] [Related]
36. Projection of future pharmacy service fees using the dispensing claims in hospital and clinic outpatient pharmacies: national health insurance database between 2006 and 2012.
Ha D; Song I; Lee EK; Shin JY
BMC Health Serv Res; 2018 May; 18(1):327. PubMed ID: 29724220
[TBL] [Abstract][Full Text] [Related]
37. Dispensing behaviour of pharmacies in prescription drug markets.
Guhl D; Stargardt T; Schneider U; Fischer KE
Health Policy; 2016 Feb; 120(2):190-7. PubMed ID: 26874903
[TBL] [Abstract][Full Text] [Related]
38. Factors influencing pharmacists' participation in third-party programmes.
Szeinbach SL
J Clin Pharm Ther; 1990 Aug; 15(4):241-5. PubMed ID: 2229204
[No Abstract] [Full Text] [Related]
39. Pharmaceutical care in community pharmacies: practice and research in the US.
Christensen DB; Farris KB
Ann Pharmacother; 2006; 40(7-8):1400-6. PubMed ID: 16868221
[TBL] [Abstract][Full Text] [Related]
40. Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.
Malone DC; Abarca J; Skrepnek GH; Murphy JE; Armstrong EP; Grizzle AJ; Rehfeld RA; Woosley RL
Med Care; 2007 May; 45(5):456-62. PubMed ID: 17446832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
